“Genetics to Treatment” BPD Awareness for Managers
Thursday, May 13th, 2010May is Borderline Personality Disorder Awareness Month. Thanks to the efforts of Perry Hoffman, Ph.D., President, and members of the Board of Directors of the National Education Alliance for Borderline Personality Disorder (NEA-BPD), the U.S. House of Representatives on April 1, 2008, acknowledged the need to bring the attention of the disorder that impacts all areas of one’s life to the attention of the general public. “All aspects of one’s life” include the workplace where managers are often at a loss to know why employees act out, demonstrate wide mood swings, or engage in self-destructive behaviors. Below is information that may help you understand your staff better.

Perry Hoffman; Marsha Linehan, Prof. of Psychology, Washington; Dale Terilli; at NEA-BPD's "Meet and Greet the Experts"
Perry and I met in 2006 when we both had suites on the same floor in an office building. Also on the same floor was the office of The Connections Place (TCP), an innovative job preparedness program for those with BPD, which was co-founded by Beth Elliott, Ph.D., and Dale Terilli. When asked if I would volunteer for TCP, I agreed to conduct mock interviews with their clients, hire those ready to get a job for project work, and give short presentations on workplace issues. Perry invited me to attend a “Family Connections” training session so that I could better understand the dimensions of BPD behaviors and the impact it has on loved ones.
A serious mental illness diagnosed more often than schizophrenia or bipolar (manic-depressive illness) combined, BPD is prevalent in an estimated 10 million Americans. According to NEA-BPD, symptoms of BPD include impulsivity, rage, bodily self-harm, recurrent suicidal behavior, unstable relationships, and frequent career changes. Often diagnosed in young adults, BPD is also diagnosed in adolescents.
A special NEA-BPD Conference, “Genetics to Treatment: Leaders Speak about Research Findings and Implications” was held at Virginia Commonwealth University in Richmond in early March. Curious about the role genetics play in the disorder—I see both clients and students who fit that diagnosis plus that was my diagnosis thirty years ago—I attended the conference coordinated by Patricia Woodward, M.A.T., Secretary/Treasurer of the NEA-BPD Board. Audio and video recordings of the “Genetics to Treatment” conference are available at the NEA-BPD website.
“The degree to which Borderline Personality Disorder is caused by inborn factors called the ‘level of inheritability’ is estimated to be 68%,” states Dr. John Gunderson in a booklet entitled, “A BPD Brief: An Introduction to Borderline Personality Disorder—Diagnosis, Origins, Course, and Treatment.” BPD itself is not inherited, he and the other excellent presenters stressed. It is the biogenetic dispositions that are passed along he emphasized during his presentation on the “Development of BPD” which included the genetics of BPD. An elder in the field of BPD, Dr. Gunderson is both a Professor of Psychiatry, Harvard Medical School, and Director, Center for Treatment and Research on BPD, Mclean Hospital, Belmont, MA.
The first presenter of the day thankfully was Dr. Kenneth S. Kendler, Rachel Brown Banks Distinguished Professor of Psychiatry at the Virginia Commonwealth University; Professor of Human Genetics; Director, Psychiatric Genetics Research Program; Director, Virginia Institute for Psychiatric and Behavioral Genetics. I was very glad that my mind was sharp early in the day and that I was sitting in the third row; I could focus my total attention on the details of the research he shared and actually understand the information he conveyed.
Instead of the details, however, following are some of the conclusions of Dr. Kendler’s presentation: “All major psychiatric and drug use disorders are heritable, although the degree of genetic influence differs substantially across disorders. For many disorders, gene action on psychiatric disorders is not static but rather is developmentally dynamic. For many disorders, genetic and environmental risk factors do not just ‘add’ together. Rather, genes influence: sensitivity to the pathogenic effect of environment stressors; probability of exposure to high risk environments. Discovering risk genes for psychiatric disorders is not purely academic as they provide the best chance we have for understanding the biological substrate of these disorders and identifying potentially new drug targets.”
How does all this information apply to managers in the workplace and what they need to know about employees’ behaviors?
One way to answer that question was part of the presentation by Dr. Robert O. Friedel, Distinguished Clinical Professor of Psychiatry, Virginia Commonwealth University, and Professor Emeritus, University of Alabama at Birmingham, who spoke about “The Treatment of BPD with Medications: A Neurobiological Approach.” Dr. Fiedel is the author of Borderline Personality Disorder Demystified: An Essential Guide for Understanding and Living with BPD. He wrote the book for two reasons: to fill the need for more factual information on the disorder and, since he knew how his sister had suffered with BPD, to try to help those with BPD.
One of the first slides he put on the screen was a picture of his sister Denise, a poignant look at a woman whose life was interrupted by a range of behaviors that evoked much pain and sorrow for her and her loved ones. Thanks to innovative therapeutic approaches and the research by the presenters and their colleagues around the world, there is a greater understanding of how to manage the appropriate medications creating a more positive prognosis for recovery from BPD.
Attending the “Genetics to Treatment” conference was challenging and extremely informative. It has given me greater confidence in having conversations with students who I think would find a visit to the college’s counseling center helpful. Using the appropriate language for a referral as an instructor is important. It is also important if you are a manager and need to suggest that an employee would benefit from speaking with someone and that they can, for instance, contact the Employee Assistance Program coordinator at your company for help. I never mention exactly why I think someone should see a counselor; that would be a diagnosis and I am not qualified to do that. What I mention is that talking with someone might be helpful to get through a stressful period or to deal with an issue now rather than later in life.
Often individuals, managers, or loved ones think that if a person tries hard enough, they can control their moods or behaviors at work or home. In truth, that’s not always the case, as I know from personal experience. People need treatment for disorders like BPD, treatment with a mental health professional who may or may not prescribe medications. However, as is becoming clearer and clearer in the field of personality disorders and other mental illnesses, genetics are lighting the path to the development of effective medications, a breakthrough for an even brighter outlook for those with BPD.

